Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Northside Hospital, Inc.